Vesyca

Vesyca

ranitidine

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries
Concise Prescribing Info
Contents
Ranitidine HCl
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Tab Adult Duodenal & gastric ulcers 300 mg daily for 4-8 wk. Maintenance: 150 mg at bedtime. GERD 150 mg bd for 8 wk. Zollinger-Ellison syndrome Initially 150 mg tds, thereafter individually adjusted. Max: 6 g daily. Prophylaxis of haemorrhage from stress ulceration in seriously ill patient or in patient bleeding from peptic ulceration currently managed by IV ranitidine 150 mg bd. Prophylaxis of acid aspiration syndrome (AAS) 150 mg in the evening prior to anaesth induction or 150 mg just before anaesth. Prevention of AAS in pre-partum patient 150 mg 6 hrly. Childn 8-18 yr Up to 150 mg bd. Inj Duodenal ulcer, benign gastric ulcer, post-op ulcer, reflux esophagitis, Zollinger-Ellison syndrome 50 mg 6-8 hrly by IM inj or slow IV inj, or 25 mg/hr for 2 hr by intermittent IV infusion. Prophylaxis of haemorrhage from stress ulceration in seriously ill patient Initially 50 mg as slow IV inj followed by 0.125-0.25 mg/kg/hr continuous IV infusion. Prophylaxis of Mendelson syndrome 50 mg by IM or slow IV inj, 45-60 min before anaesth induction.
Administration
May be taken with or without food.
Special Precautions
Exclude gastric malignancy. History of acute porphyria & peptic ulcer. Concurrent NSAID therapy especially in elderly. Renal or hepatic impairment. Pregnancy & lactation. Childn <2 yr.
Adverse Reactions
Changes in LFTs, hepatitis, blood count changes, hypersensitivity reactions, bradycardia, AV block, asystole, headache, dizziness, mental confusion, depression, hallucination, blurred vision, skin rash, musculoskeletal symptoms.
Drug Interactions
Sucralfate.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Vesyca FC tab 150 mg
Packing/Price
50 × 10's
Form
Vesyca inj 25 mg/mL
Packing/Price
2 mL x 50 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in